Edge Wealth Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,095	Closed	-$482K	–	458
2020 Q4	$482K	Buy	3,095 +188	+6%	+$24.2K	0.11%	68
2020 Q3	$333K	Sell	2,907 -250	-8%	-$27K	0.08%	83
2020 Q2	$354K	Hold	3,157	–	–	0.07%	111
2020 Q1	$284K	Hold	3,157	–	–	0.06%	121
2019 Q4	$341K	Buy	3,157 +187	+6%	+$20K	0.07%	117
2019 Q3	$290K	Buy	2,970 +1,562	+111%	+$176K	0.07%	116
2019 Q2	$182K	Sell	1,408 -60	-4%	-$7.73K	0.04%	148
2019 Q1	$199K	Hold	1,468	–	–	0.05%	134
2018 Q4	$143K	Sell	1,468 -555	-27%	-$65.6K	0.04%	157
2018 Q3	$281K	Sell	2,023 -315	-13%	-$39.5K	0.07%	118
2018 Q2	$290K	Buy	2,338 +400	+21%	+$46.7K	0.07%	119
2018 Q1	$216K	Sell	1,938 -4,121	-68%	-$493K	0.06%	119
2017 Q4	$727K	Sell	6,059 -630	-9%	-$76.7K	0.21%	68
2017 Q3	$935K	Sell	6,689 -5,951	-47%	-$809K	0.28%	55
2017 Q2	$1.58M	Buy	+12,640	New	+$1.47M	0.5%	33
2017 Q1	–	Sell	-160	Closed	-$20K	–	544
2016 Q4	$20K	Buy	+160	New	+$19.6K	0.01%	278
2016 Q2	–	Sell	-452	Closed	-$63K	–	496
2016 Q1	$63K	Buy	+452	New	+$66.4K	0.03%	159